Skip to content

Sterile Compounding: Ensuring Safe Prep of Parenteral Nutrition CSPs - 2021/2022 Update

Live Online Webinar
December 3, 2021 | 2:00 PM - 3:00 PM EST

This activity is intended for practicing pharmacists who work in or oversee sterile compounding processes and procedures. 

Learning Objectives

At the completion of this activity, the participant will be able to:

  • Discuss the safety issues associated in the parenteral nutrition (PN) compounding process
  • Describe how knowledge deficits can lead to PN compounding errors
  • Explain the factors that can lead to calcium-phosphate precipitation in a PN solution.
  • Determine where errors occur depending upon the method of PN compounding used.

Presenter

Kathleen M. Gura, PharmD, BCNSP, FASHP, FPPA, FASPEN, FMSHP is the manager for Pharmacy Research Program and a member of the Clinical Nutrition Service in the Division of GI/Nutrition at Boston Children's Hospital. Dr. Gura is an Assistant Professor of Pediatrics at Harvard Medical School, and is an adjunct faculty member at MCPHS University, Northeastern University and the University of Connecticut. She is a member of the Center for Advanced Intestinal Rehabilitation and the Home PN Program at Boston Children’s Hospital. Dr. Gura received her BS and PharmD from Massachusetts College of Pharmacy and Health Sciences in Boston. Certified as a Nutritional Support Pharmacist, Dr. Gura is a Fellow of the ASHP, ASPEN, PPA and MSHP. She was named the 2020 Nutrition Champion by the American Society for Parenteral and Enteral Nutrition and the winner of the 2021 Oley Foundation’s Research Award. Dr. Gura is the author of numerous book chapters on pediatric nutrition and has written more than 140 peer reviewed articles on topics such as the intestinal failure associated liver disease, parenteral nutrition compounding, and the use of parenteral nutrition in the neonate. She recently served as an associate editor for JPEN and joined the board of directors for ASPEN in June 2021. She is currently a member of the FDA’s Pharmaceutical Compounding Advisory Committee.

There is no fee to attend this activity. Registration is required to earn ACPE credit. This webinar will be hosted on Zoom.

Register


ACPE logo

UAN 0026-0000-21-032-L07-P
Knowledge -based
Topic Designator: Compounding

Accreditation

Massachusetts College of Pharmacy and Health Sciences (MCPHS) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 2 contact hours (0.2 CEUs).

Requirements for Credit

Partial credit will not be awarded. To claim credit participants must log into their profile on MCPHS CE portal and insert the specific activity code for this webinar in order to access and complete the evaluation. CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours.

Attendance will be verified. Credit will not be issued to participants who join the meeting more than 15 minutes after the start of the meeting or to those who depart early. Credit cannot be awarded to individuals who complete the activity evaluation more than 60 days post activity.

Evaluation

All participants will have the opportunity to review the educational session and speakers, and to identify future educational needs.

Statement of Disclosure

MCPHS adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies, and that relevant conflicts of interest are mitigated. Speakers will disclose any unlabeled/unapproved use of drugs or devices during their presentation.

MCPHS  Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.
Kaelen Dunican and Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.